Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological Assays
文献类型:期刊论文
作者 | Chen, Shijie2,3; Li, Linjuan2,3; Chen, Yantao3; Hu, Junchi3; Liu, Jingqiu3; Liu, Yu-Chih4; Liu, Rongfeng4; Zhang, Yuanyuan3; Meng, Fanwang3; Zhu, Kongkai3 |
刊名 | JOURNAL OF CHEMICAL INFORMATION AND MODELING
![]() |
出版日期 | 2016-03 |
卷号 | 56期号:3页码:527-534 |
ISSN号 | 1549-9596 |
DOI | 10.1021/acs.jcim.5b00738 |
文献子类 | Article |
英文摘要 | Histone methyltransferases are involved in many important biological processes, and abnormalities in these enzymes are associated with tumorigenesis and progression. Disruptor of telomeric silencing 1-like (DOT1L), a key hub in histone lysine methyltransferases, has been reported to play an important role in the processes of mixed-lineage leukemia (MLL)-rearranged leukemias and validated to be a potential therapeutic target. In this study, we identified, a novel DOT1L inhibitor, DC_L115 (CAS no. 1163729-79-0), by combining structure-based virtual screening with biochemical analyses. This potent inhibitor DC_L115 shows high inhibitory activity toward DOT1L (IC50 = 1.5 mu M). Through a process of surface plasmon resonance-based binding assays, DC_L115 was founded to bind to DOT1L with a binding affinity of 0.6 mu M in vitro. Moreover, this compound selectively inhibits MLL-rearranged cell proliferation with an IC50 value of 37.1 mu M. We further predicted the binding modes of DC_L115 through molecular docking analysis and found that the inhibitor competitively occupies the binding site of S-adenosylmethionine. Overall, this study demonstrates the development of potent DOT1L inhibitors with novel scaffolds. |
WOS关键词 | HISTONE METHYLTRANSFERASE DOT1L ; MLL-REARRANGED LEUKEMIA ; DRUG DISCOVERY ; SELECTIVE INHIBITORS ; H3K79 METHYLATION ; ACCURATE DOCKING ; FUSION PARTNERS ; SET DOMAIN ; POTENT ; GLIDE |
资助项目 | National Basic Research Program[2015CB910304] ; Hi-Tech Research and Development Program of China[2014AA01A302] ; National Natural Science Foundation of China[21210003] ; National Natural Science Foundation of China[81230076] ; National Natural Science Foundation of China[81430084] ; National Natural Science Foundation of China[81202398] ; National Natural Science Foundation of China[91229204] ; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"[2013ZX09507-004] ; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"[2013ZX09507001] ; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"[2014ZX09507002-005-012] |
WOS研究方向 | Pharmacology & Pharmacy ; Chemistry ; Computer Science |
语种 | 英语 |
WOS记录号 | WOS:000373247200008 |
出版者 | AMER CHEMICAL SOC |
源URL | [http://119.78.100.183/handle/2S10ELR8/276117] ![]() |
专题 | 药物发现与设计中心 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Jiang, Hualiang; Yao, Zhiyi; Luo, Cheng |
作者单位 | 1.Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Urol, Shanghai 200127, Peoples R China; 2.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; 3.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, 555 Zu Chongzhi Rd, Shanghai 201203, Peoples R China; 4.Shanghai ChemPartner LifeSci Co Ltd, Vitro Biol, 5 Bldg,998 Halei Rd, Shanghai 201203, Peoples R China; 5.Shanghai Inst Technol, Coll Chem & Environm Engn, Shanghai 210032, Peoples R China |
推荐引用方式 GB/T 7714 | Chen, Shijie,Li, Linjuan,Chen, Yantao,et al. Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological Assays[J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING,2016,56(3):527-534. |
APA | Chen, Shijie.,Li, Linjuan.,Chen, Yantao.,Hu, Junchi.,Liu, Jingqiu.,...&Luo, Cheng.(2016).Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological Assays.JOURNAL OF CHEMICAL INFORMATION AND MODELING,56(3),527-534. |
MLA | Chen, Shijie,et al."Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological Assays".JOURNAL OF CHEMICAL INFORMATION AND MODELING 56.3(2016):527-534. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。